Monthly Archives: November 2016

Recent Buy – BNS, GSK, TOT

I’m looking for companies that are fairly valued, have a decent dividend yield(3% to 6%) and have a fairly long history of paying dividends consistently for 10 years or more. However, there could be some cases for exceptionally good company or a strategic buy for a very long term.

With market setting all time highs almost on a daily basis, it’s getting difficult to find companies at fair valuation. However, I nibbled following companies in Nov, 2016:

1) Bank of Nova Scotia (BNS)
This is my 13th buy of BNS this year, a marathon buying spree so far! It turns out to be 1+ buy per month on average. I added 5 positions in BNS on 11/07 at $53.59. It’ll add $14.80 of passive dividend income on an annual basis.

2) GlaxoSmithKline (GSK)
I’ve been thinking to add some pharma companies since sometime and GSK fits nicely into the portfolio, with the demographics favoring these companies. I added 10 positions in GSK on 11/09 at $40.21. It’ll add $28.80 on an annualized basis.

3) Total S.A .(TOT)
Its no secret that oil segment has gone thru a rough patch and from prior depth of abyss, it has nicely recovered over last several months. OPEC is playing cat and mouse deal or no-deal game with the market. Irrespective of this,  O&E companies are long-term hold and TOT fits nicely into my diversified energy portfolio. I bought 5 positions in TOT at $47.69 on 11/02 and it’ll add $12.20 of passive income on an annual basis.

Full Disclosure: Long on above mentioned securities.

Thanks for reading.